News Release

Availability of medications for opioid use disorder in opioid treatment programs

JAMA Network Open

Peer-Reviewed Publication

JAMA Network

About The Study: In this cross-sectional study of opioid treatment programs (OTPs), although the availability of medications for opioid use disorder (MOUD) beyond methadone increased over time, most OTPs still did not offer all 3 forms of MOUD as of 2023. Specific organizational characteristics, such as being government operated and accepting Medicare, were associated with more comprehensive MOUD offerings. Future research should evaluate why OTPs vary in their MOUD offerings. 

Corresponding Author: To contact the corresponding author, Zoe Lindenfeld, PhD, email zoe.lindenfeld@rutgers.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2025.17616)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.17616?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062625

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.